IN2012DN01273A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01273A IN2012DN01273A IN1273DEN2012A IN2012DN01273A IN 2012DN01273 A IN2012DN01273 A IN 2012DN01273A IN 1273DEN2012 A IN1273DEN2012 A IN 1273DEN2012A IN 2012DN01273 A IN2012DN01273 A IN 2012DN01273A
- Authority
- IN
- India
- Prior art keywords
- compound
- formula
- disease
- treating
- pharmaceutically acceptable
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000002875 cyclin dependent kinase inhibitor Substances 0.000 abstract 1
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27593809P | 2009-09-04 | 2009-09-04 | |
| US28496209P | 2009-12-28 | 2009-12-28 | |
| PCT/EP2010/062881 WO2011026904A1 (fr) | 2009-09-04 | 2010-09-02 | Pyraziniylpyridines utilisées dans le traitement des maladies prolifératives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN01273A true IN2012DN01273A (fr) | 2015-05-15 |
Family
ID=43480986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1273DEN2012 IN2012DN01273A (fr) | 2009-09-04 | 2010-09-02 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20120165306A1 (fr) |
| EP (1) | EP2473505A1 (fr) |
| KR (1) | KR20120076352A (fr) |
| CN (1) | CN102482265A (fr) |
| AU (1) | AU2010291199A1 (fr) |
| BR (1) | BR112012004836A2 (fr) |
| CA (1) | CA2772265A1 (fr) |
| IN (1) | IN2012DN01273A (fr) |
| MX (1) | MX2012002758A (fr) |
| WO (1) | WO2011026904A1 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8415381B2 (en) * | 2009-07-30 | 2013-04-09 | Novartis Ag | Heteroaryl compounds and their uses |
| US20130303507A1 (en) * | 2011-01-28 | 2013-11-14 | Novartis Ag | Substituted hetero-biaryl compounds and their uses |
| WO2012101064A1 (fr) * | 2011-01-28 | 2012-08-02 | Novartis Ag | Composés à base de n-acyl-pyrimidine-biaryl convenant comme inhibiteurs de protéine kinase |
| WO2014106606A1 (fr) * | 2013-01-05 | 2014-07-10 | F. Hoffmann-La Roche Ag | Nouvelle série phényle/pyridine substituée par hydroxyéthylamino pour le traitement du cancer |
| HK1223927A1 (en) | 2013-09-12 | 2017-08-11 | Sumitomo Chemical Company, Limited | Nitrogen-containing saturated heterocyclic compound |
| JO3589B1 (ar) | 2014-08-06 | 2020-07-05 | Novartis Ag | مثبطات كيناز البروتين c وطرق استخداماتها |
| EP3804724B1 (fr) | 2016-10-20 | 2022-12-07 | Pfizer Inc. | Inhibiteurs de cdk pour le traitement de la htap |
| US12211592B2 (en) | 2018-07-17 | 2025-01-28 | Kuano Ltd. | Machine learning based methods of analysing drug-like molecules |
| AU2020401999B2 (en) * | 2019-12-09 | 2024-01-18 | Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Compound as cyclin-dependent kinase 9 inhibitor and use thereof |
| GB202013419D0 (en) | 2020-08-27 | 2020-10-14 | Kuano Ltd | Transition state 2020 |
| CN115381824B (zh) * | 2021-05-24 | 2024-11-05 | 石药集团中奇制药技术(石家庄)有限公司 | 周期蛋白依赖性激酶9抑制剂的用途 |
| CN115381823B (zh) * | 2021-05-24 | 2024-11-05 | 石药集团中奇制药技术(石家庄)有限公司 | 一种周期蛋白依赖性激酶9抑制剂的用途 |
| WO2022257965A1 (fr) * | 2021-06-09 | 2022-12-15 | 石药集团中奇制药技术(石家庄)有限公司 | Inhibiteur de kinase 9 dépendante de la cycline sous forme solide et son utilisation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT72878B (en) | 1980-04-24 | 1983-03-29 | Merck & Co Inc | Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents |
| DK1330452T3 (da) * | 2000-09-20 | 2009-03-16 | Ortho Mcneil Janssen Pharm | Pyrazinderivater som modulatorer af tyrosinkinaser |
| CA2514733A1 (fr) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Compositions pharmaceutiques a base d'un co-cristal |
| AU2007336933A1 (en) * | 2006-12-22 | 2008-07-03 | Novartis Ag | Heteroaryl-heteroaryl compounds as CDK inhibitors for the treatment of cancer, inflammation and viral infections |
-
2010
- 2010-09-02 CN CN2010800392830A patent/CN102482265A/zh active Pending
- 2010-09-02 BR BR112012004836A patent/BR112012004836A2/pt not_active IP Right Cessation
- 2010-09-02 KR KR1020127008621A patent/KR20120076352A/ko not_active Withdrawn
- 2010-09-02 AU AU2010291199A patent/AU2010291199A1/en not_active Abandoned
- 2010-09-02 WO PCT/EP2010/062881 patent/WO2011026904A1/fr not_active Ceased
- 2010-09-02 IN IN1273DEN2012 patent/IN2012DN01273A/en unknown
- 2010-09-02 CA CA2772265A patent/CA2772265A1/fr not_active Abandoned
- 2010-09-02 US US13/393,457 patent/US20120165306A1/en not_active Abandoned
- 2010-09-02 MX MX2012002758A patent/MX2012002758A/es not_active Application Discontinuation
- 2010-09-02 EP EP10748097A patent/EP2473505A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120076352A (ko) | 2012-07-09 |
| US20120165306A1 (en) | 2012-06-28 |
| WO2011026904A1 (fr) | 2011-03-10 |
| EP2473505A1 (fr) | 2012-07-11 |
| MX2012002758A (es) | 2012-04-19 |
| CA2772265A1 (fr) | 2011-03-10 |
| AU2010291199A1 (en) | 2012-03-08 |
| BR112012004836A2 (pt) | 2019-09-24 |
| CN102482265A (zh) | 2012-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN01273A (fr) | ||
| MX2012002752A (es) | Compuestos de heteroarilo como inhibidores de cinasa. | |
| MX2012002761A (es) | Bipiridinas utiles para el tratamiento de enfermedades proliferativas. | |
| WO2011123946A8 (fr) | Inhibiteurs de kinases et procédé de traitement du cancer utilisant ceux-ci | |
| UA105794C2 (uk) | 1,3-ДИЗАМІЩЕНІ ПОХІДНІ ІМІДАЗОЛІДИН-2-ОНУ ЯК ІНГІБІТОРИ Cyp17 | |
| WO2010151710A3 (fr) | Composés hétérocycliques substitués utilisés en tant qu'inhibiteurs de la kinase et leur procédé d'utilisation | |
| TN2011000400A1 (en) | Inhibitors of beta-secretase | |
| MX2011009796A (es) | Inhibidores de la cinasa pi3. | |
| TN2011000293A1 (en) | Protein kinase inhibitors | |
| AU2012214029A8 (en) | Rorgammat inhibitors | |
| WO2010135524A8 (fr) | Inhibiteurs de pi3k/mtor à base de benzoxazépines pour lutter contre les maladies prolifératives | |
| WO2012068096A3 (fr) | Benzoxazépines en tant qu'inhibiteurs de pi3k/mtor et leurs méthodes d'utilisation et de fabrication | |
| WO2012068106A3 (fr) | Benxazépines en tant qu'inhibiteurs de pi3k/mtor et leurs procédés d'utilisation et de fabrication | |
| MX2013005826A (es) | Benzoxazepinas como inhibidores de fosfatidilinositol 3-cinasa/objetivo de rapamicina en mamiferos (p13k/mtor) y metodos de uso y fabricacion. | |
| TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
| MX2012015098A (es) | Compuestos heterociclicos fusionados como inhibidores de fosfodiesterasas (pdes). | |
| MY170922A (en) | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives | |
| GEP20125708B (en) | Hydroxamate-based inhibitors of deacetylases b | |
| MX2010008460A (es) | Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular. | |
| UA105527C2 (uk) | Сполука-інгібітор матриптази для лікування раку | |
| MX2010008226A (es) | Derivados de difluorobifenilamida para el tratamiento de hipertension ocular. | |
| UA101091C2 (ru) | Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой | |
| WO2010123545A3 (fr) | Inhibiteurs de l'angiogenèse | |
| EA201200868A1 (ru) | Ингибиторы диацилглицеролацилтрансферазы | |
| MX2009004982A (es) | Derivados heterociclicos como inhibidores cetp. |